Isabel M Álvarez

4PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 26, 2026
Sensitivity to endocrine therapy index predicts benefit from weekly adjuvant paclitaxel for hormone receptor-positive breast cancer in the GEICAM/9906 trial.

|Dec 12, 2025
Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2- Highly Proliferative Breast Cancer.

Miguel Martín, Ángel L Guerrero-Zotano, María E Pérez-López

|Jul 24, 2021
Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer.

José Manuel López-Vega, Isabel Álvarez, Antonio Antón

|Feb 14, 2020
Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer.

I Alvarez-Lopez, S Bezares, E Dalmau Portulas

Pageof 1

Frequent Collaborators

2 joint publications

Rosalía Caballero

2 joint publications

Federico Rojo

2 joint publications

José J Ponce-Lorenzo

2 joint publications

Miguel Martín